Rigvir Group has signed a licence agreement with a UK-based company Smart Nanovirus Limited on a fundamentally new approach to cancer prevention, that would allow to identify high cancer risks timely and address them effectively, using the oncolytic virus Rigvir.
Rigvir Group has signed a licence agreement with a UK-based
company Smart Nanovirus Limited on a fundamentally new approach to cancer prevention, that would
allow to identify high cancer risks timely and address them effectively, using the oncolytic
virus Rigvir.
Henceforth, the Rigvir virus is going to be developed also in the non-medical field which could
provide preventive help to people with high cancer-risks or scientifically proven cancer
presence in the body even before cancer can be diagnosed.
It is known that Rigvir virus is successfully used in cancer treatment and prevention of
metastasis in cancer patients. Rigvir virus possesses natural intelligence – the ability to
independently seek and destroy circulating tumour cells in the human body, activate the immune
system response against cancer and selectively kill cancer cells without affecting healthy
cells.
Cancer prevention is insufficiently developed in the medical field; we all know it, and many
international organisations point to it too. According to the World Health Organisation (WHO),
one in 5 men and one in 6 women worldwide develops cancer during their lifetime.¹ The only
cancer prevention today according to the WHO² is the recommendation to change lifestyle. There
is no registered target cancer prevention supplement in the market with a serious medical and
scientific background.
Today, we have access to unique novelty technologies or early warning solutions that allow
scientifically to identify cancer presence before cancer starts to develop and clinical symptoms
show up, for example, by detecting circulating tumour cells in the human body. Sadly, modern
medicine is unable to properly respond to such technology challenges. The next generation
medications are mostly intended for late stages only; and a number of international cancer
treatment guidelines recommend observation to early stages.
Also, modern medicine underestimates digital solutions that can speed-up significantly
prevention and treatment process and often help save time as well as money – in many cases of
such great importance to successfully battle cancer.
We are sure that a combination of the mentioned technologies in synergy with Rigvir virus can
change the paradigm of oncology by offering a real and effective solution to eradicate cancer
problem at the root.
More information on the Natural Intelligence Cancer Prevention Project: www.smartnanovirus.com.
1 https://www.who.int/cancer/PRGlobocanFinal.pdf
2 https://www.who.int/health-topics/cancer